首页> 外文OA文献 >A hypothesized TNM staging system based on the number and location of positive lymph nodes may better reflect the prognosis for patients with NSCLC
【2h】

A hypothesized TNM staging system based on the number and location of positive lymph nodes may better reflect the prognosis for patients with NSCLC

机译:基于阳性淋巴结的数量和位置的假设TNM分期系统可以更好地反映NSCLC患者的预后

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Abstract Background This study aimed to evaluate the feasibility and prognostic accuracy of incorporating the number of positive lymph nodes (PLN) into the TNM staging system for non-small cell lung cancer (NSCLC) patients. Methods We screened a total of 9539 patients with resected stage IA-IIIB non-small cell cancer between 2010 and 2015 from SEER database. The chi-square test was used to compare patient baseline characteristics and the X-tile model was applied to determine cut-off values for the number of PLN (nN). The X-tile model was used to screen three different cut-off values including nN = 0, nN1–3 and nN4-. Univariate and multivariate Cox proportional hazards regression models were used to analyze the influence of different variables on overall survival (OS). Kaplan-Meier and log-rank test were used to compare survival differences. Results Based on the nN cutoffs, we conducted the univariate and multivariate Cox proportional hazards regression. The result showed that nN stage was a significant prognostic factor affecting patients' OS (all P <  0.001). We reclassified the seventh edition TNM stages of the enrolled patients with stage IA-IIIB NSCLC according to the 5-year OS rate. Hypothesized TNM substage based on the location and the number of PLN was further calculated. Then we drew survival curves for each substage, including for the current TNM stage and the hypothesized TNM stage. From the comparison of survival curves, we found that the survival curve of each substage of the hypothesized TNM classification was proportional and well distributed compared with the current TNM classification (P <  0.001). Conclusion Revised TNM staging integrating locational pN stage and numerical nN stage was a more accurate prognostic determinant in patients with NSCLC.
机译:摘要背景本研究旨在评估将阳性淋巴结数(PLN)掺入非小细胞肺癌(NSCLC)患者的TNM分期系统的可行性和预后准确性。方法从SEER数据库中筛选了2010年至2015年间切除阶段IA-IIIB非小细胞癌的9539名患者。 Chi-Square测试用于比较患者基线特性,并且应用X瓦模型来确定PLN数量的截止值(NN)。 X-Tile模型用于筛选三个不同的截止值,包括NN = 0,NN1-3和NN4-。单变量和多变量的Cox比例危险危害回归模型用于分析不同变量对整体存活(OS)的影响。 Kaplan-Meier和日志秩测试用于比较生存差异。结果基于NN截止值,我们进行了单变量和多变量的Cox比例危害回归。结果表明,NN阶段是影响患者OS的重要预后因素(所有P <0.001)。我们根据5年的操作系统率重新分类了注册患者的第七版TNM阶段,舞台IA-IIIB NSCLC。进一步计算了基于位置和PLN的数量的假设的TNM聚物。然后我们制定了每种商品的存活曲线,包括当前TNM阶段和假设的TNM阶段。根据存活曲线的比较,我们发现假设的TNM分类的每种物质的存活曲线与当前TNM分类相比,分布比例,分布得很好(P <0.001)。结论修订了TNM分期集成位置PN阶段和数值NN阶段是NSCLC患者的更准确的预后决定因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号